Impact of cytokines on diffuse splenic F-18-fluorodeoxyglucose uptake during positron emission tomography/computed tomography
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q2
- 저널
- NUCLEAR MEDICINE COMMUNICATIONS34(1) · pp.64 · 2013
- 피인용
- Web of Science 25
- JCR IF
- JCR 2012 1.379
- ISSN
- 0143-3636
저자
- 박경준제1저자Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
- 김성장교신저자Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
- 김인주Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
- 김동욱ADepartment of Internal Medicine, Medical Research Institute, Pusan National University Hospital, South Korea
- 김근영Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
- 김희영Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
초록
Objectives Concurrent inflammation or anemia at the time of PET/computed tomography (CT) could be one of several causes of diffuse splenic F-18-fluorodeoxyglucose (F-18-FDG) uptake. In this study, we focused on cytokines to investigate interactions during this phenomenon and clarify the significance of splenic F-18-FDG uptake in PET/CT. Methods We selected 40 patients (17 women and 23 men) with cholangiocarcinoma, pancreatic cancer, or gallbladder cancer who had undergone PET/CT. These patients were subdivided into two groups (group A: patients showing splenic F-18-FDG uptake exceeding hepatic uptake; group B: patients showing hepatic F-18-FDG uptake exceeding splenic uptake). Blood sampling was performed for each patient on the same day as PET/CT, and 22 types of cytokines and hematologic indices were analyzed. Results Group A showed higher levels of interleukin (IL)-1 beta (P=0.0478), IL-1RA (P=0.0044), IL-4 (P=0.0118), IL-6 (P=0.0375), IL-7 (P=0.0478), and IL-13 (P=0.0081) compared with group B. However, interferon-inducible protein-10 (IP-10; P=0.1714), IL-9 (P=0.8022), IL-8 (P=0.1631), IL-5 (P=0.5273), IL-3 (P=0.3097), IL-23 (P=0.1194), IL-2 (P=0.1099), IL-1 alpha (P=0.4439), IL-17 alpha (P=0.8811), IL-16 (P=0.3201), IL-15 (P=0.0580), interferon-gamma (IFN-gamma; P=0.5308), growth-regulated oncogene (GRO; P=0.2847), granulocyte macrophage-colony-stimulating factor (GM-CSF; P=0.0913), granulocyte-colony-stimulating factor (G-CSF; P=0.5244), and soluble CD40 ligand (sCD40L; P=0.1714) levels in group A were not statistically significantly different compared with those in the control group. In addition, the white blood cell counts and C-reactive protein levels in group A showed higher values compared with group B. IL-13 among the cytokines and C-reactive protein among the hematologic indices were significant predictors of splenic F-18-FDG uptake exceeding hepatic F-18-FDG uptake. Conclusion This study showed that splenic F-18-FDG uptake is related to IL-1 beta, IL-1 receptor antagonist, IL-4, IL-6, IL-7, and IL-13. These cytokines may reflect the activation of humoral immunity of the spleen. Nucl Med Commun 34:64-70 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins. Nuclear Medicine Communications 2013, 34:64-70
키워드
cytokinesF-18-fluorodeoxyglucosepositron emission tomography and computed tomographyspleenGROWTH-FACTORFDG-PETINTERLEUKIN-6PATHOGENESISINFECTIONPROTEINDISEASECANCER
식별자
- WoS UID
- 000312512300011



로그인
연구물 목록으로